Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
44.26
+0.86 (1.98%)
Oct 27, 2025, 12:45 PM EDT - Market open
Artivion Revenue
Artivion had revenue of $112.97M in the quarter ending June 30, 2025, with 15.26% growth. This brings the company's revenue in the last twelve months to $405.04M, up 7.44% year-over-year. In the year 2024, Artivion had annual revenue of $388.54M with 9.75% growth.
Revenue (ttm)
$405.04M
Revenue Growth
+7.44%
P/S Ratio
4.56
Revenue / Employee
$253,148
Employees
1,600
Market Cap
2.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 388.54M | 34.53M | 9.75% |
| Dec 31, 2023 | 354.00M | 40.22M | 12.82% |
| Dec 31, 2022 | 313.79M | 14.95M | 5.00% |
| Dec 31, 2021 | 298.84M | 45.61M | 18.01% |
| Dec 31, 2020 | 253.23M | -23.00M | -8.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
AORT News
- 3 days ago - Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results - PRNewsWire
- 14 days ago - Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - PRNewsWire
- 6 weeks ago - Artivion, Inc. (AORT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 7 weeks ago - Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference - PRNewsWire
- 7 weeks ago - Share Growth And Strong Clinical Results Continue To Support The Artivion Story - Seeking Alpha
- 2 months ago - Artivion, Inc. (AORT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Artivion Reports Second Quarter 2025 Financial Results - PRNewsWire
- 3 months ago - Artivion to Participate in Upcoming Investor Conferences - PRNewsWire